- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Mallcom (India) Limited — Investor Meet, 18-11-2024: Analysts/Institutional Investor Meet/Con. Call Updates
Financial Performance: Mallcom (India) Limited reported consolidated operating revenue of approximately ₹129 crore, marking a remarkable growth of nearly 90% year-over-year. EBITDA was around ₹16 crore, reflecting a 3% rise but with a margin drop to 12.24%, attributed to increased spending on branding and self-promotion. The net profit rose to approximately ₹10 crore, up 10% YoY, yielding a PAT margin of 7.82%. For the first half of the fiscal year, revenue grew 14% to ₹232 crore, with net profit reaching ₹19 crore, a 5% increase.
Future Outlook and Growth Drivers: Management highlighted expectations for sustained growth driven by a surge in both B2B and B2C demands, facilitated by a new e-commerce platform. The industrial safety market is set to expand with the launch of new product lines including gloves and helmets, indicating a strategic focus on innovation and quality.
Order Book and Operational Updates: The Gujarat project is on track for trial runs of the new dipped glove manufacturing by month-end, with potential revenues from the facility estimated at ₹100 crore within three years. Ongoing projects in Ghatakpukur are also progressing as planned.
Analyst Q&A Insights: Analysts inquired about revenue projections and operational challenges. Management affirmed strong revenue trajectory but noted margin pressures due to increased operational costs. Competitive landscape discussions indicated positive demand dynamics, particularly in the U.S. and Europe, amid logistics challenges.
Strategic Focus Areas: Key strategic themes include leveraging heightened safety standards and expanding the distributor base in both domestic and international markets.
Investor Insight: The company's strong revenue growth and strategic investments in operations indicate a favorable long-term outlook. The financial health suggests potential alignment with a 'buy' stance, with future risks mainly linked to operational efficiencies and market dynamics.